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Abstract: Strong observational evidence supports the association between obesity and
cardiovascular events. In elderly high-risk subjects, the Mediterranean diet (MedDiet) was reported
to counteract the adverse cardiovascular effects of adiposity. Whether this same attenuation
is also present in younger subjects is not known. We prospectively examined the association
between obesity and cardiovascular clinical events (myocardial infarction, stroke or cardiovascular
death) after 10.9 years follow-up in 19,065 middle-aged men and women (average age 38 year)
according to their adherence to the MedDiet (<6 points or ě6 points in the Trichopoulou’s
Mediterranean Diet Score). We observed 152 incident cases of cardiovascular disease (CVD). An
increased risk of CVD across categories of body mass index (BMI) was apparent if adherence to the
MedDiet was low, with multivariable-adjusted hazard ratios (HRs): 1.44 (95% confidence interval:
0.93–2.25) for ě25 – <30 kg/m2 of BMI and 2.00 (1.04–3.83) for ě30 kg/m2 of BMI, compared to
a BMI < 25 kg/m2. In contrast, these estimates were 0.77 (0.35–1.67) and 1.15 (0.39–3.43) with
good adherence to MedDiet. Better adherence to the MedDiet was associated with reduced CVD
events (p for trend = 0.029). Our results suggest that the MedDiet could mitigate the harmful
cardiovascular effect of overweight/obesity.
Keywords: obesity; Mediterranean diet; prospective cohort study; cardiovascular disease;
SUN project
1. Introduction
The prevalence of obesity is increasing globally, and it is one of the major public health problems
in most countries. According to WHO, in the last three decades the prevalence of obesity has doubled
worldwide. As a result, the majority of world population currently live in countries where overweight
and obesity cause more deaths than insufficient weight [1].
Excess body weight is likely to be associated with clinical cardiovascular disease (CVD) even at
moderate levels of overweight and independently of traditional cardiovascular risk factors [2–5]. On
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the other hand, dietary habits play an important role as determinants of optimal health and—more
importantly—they may be especially useful for the prevention of CVD [6,7]. There is compelling
evidence that the traditional Mediterranean diet (MedDiet) has beneficial effects against all-cause
mortality and clinical cardiovascular events [8–10]. In the context of the current pandemic of
overweight/obesity, it is likely that dietary habits in line with the traditional Mediterranean dietary
pattern may attenuate the well-known detrimental effects of adiposity on cardiovascular risk. In this
line of thought, a recent study conducted in elderly high-risk subjects suggested that the MedDiet
could counteract the adverse cardiovascular effects of an increased body weight [11]. It is not known
whether this attenuation by the MedDiet of the harmful cardiovascular effects of even a moderate
degree of excess adiposity is also present in younger subjects at lower cardiovascular risk. We
prospectively assessed the association between obesity and incidence of major clinical cardiovascular
events within categories of adherence to the MedDiet in a sample of 19,065 highly educated men
and women followed-up for a mean period of 10.9 years, with mean age of 38 years old and a low
predicted risk of cardiovascular disease at baseline.
2. Experimental Section
2.1. Study Population
The SUN project is a multipurpose prospective Spanish cohort study entirely composed of
university graduates. This cohort was designed to assess associations of diet or lifestyle with
the incidence of several chronic diseases and mortality. The study protocol was approved by the
Institutional Review Board of the University of Navarra. The design, methods and objectives of the
SUN project have been described previously [12].
The recruitment of participants started in December 1999. It is a dynamic cohort permanently
open to recruitment of new participants. Up to December 2014, 22,175 participants had answered the
baseline questionnaire. Follow-up information is collected through self-administered questionnaires
sent biennially by mail.
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Figure 1. Flow-chart of participants in the SUN Project, 1999–2014.
For the present analysis, 2718 participants were lost to follow up or were recruited for the cohort
only for a short period (less than 2 years) and were therefore excluded from our analyses; in addition,
386 participants with total daily energy intake beyond percentiles 1 or 99 were also excluded. Thus,
our final sample included 19,065 participants (Figure 1).
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2.2. Anthropometric Variables
Participants’ weight was recorded at baseline. Reliability and validity of self-reported weight has
been previously assessed in a subsample of the cohort, and has shown a high correlation with directly
measured weight (r = 0.99; 95% CI: 0.99, 0.99) and a mean relative error of 1.45% [13]. Body mass index
(BMI), defined as weight in kilograms divided by the square of height in meters, was computed in
the baseline questionnaire. Reliability of self-reported weight and height used to calculate BMI has
been previously assessed [13] (r = 0.94; 95% CI: 0.91, 0.97). Mean relative error in self-reported BMI
was 2.64%.
2.3. Dietary Assessment
Usual diet was assessed at baseline with a validated semi-quantitative 136-item food-frequency
questionnaire (FFQ) [14,15]. Each item included a typical portion size, and consumption frequencies
were grouped in nine categories that ranged from “never or almost never” to “ě6 times/day.”
A trained team of dietitians updated the nutrient data bank using the latest available information
included in food composition tables for Spain [16,17]. We used the Mediterranean Diet Score
(ranging from 0 to 9 points) proposed by Trichopoulou et al. [18] to classify participants according
to their baseline adherence to the Mediterranean diet [19]. One point was assigned to persons whose
consumption was at or above the sex-specific median of components frequently consumed in the
context of traditional Mediterranean diet (vegetables, fruits/nuts, legumes, fish/seafood, cereals, and
monounsaturated/saturated (MUFA/SFA) fat ratio). The participant received also 1 point if her or
his intake was below the median for the 2 components less frequently consumed in the context of
traditional Mediterranean diet (meat and dairy products). For ethanol, 1 point was assigned only for
moderate amounts of intake (5–25 g/day for women or 10–50 g/day for men.). We dichotomized
adherence to MedDiet into 2 categories (<6 and ě6 points in the Trichopoulou’s score).
2.4. Other Covariates
We used standardized questionnaires included in the baseline questionnaire to gather
information about socio-demographic parameters (sex, age), anthropometric measurements (weight,
BMI) and health-related habits (smoking status, physical activity, sedentary lifestyle). Information
on physical activity was collected at baseline through a previously validated questionnaire that
contained time spent in 17 different activities. Physical activity was expressed in metabolic
equivalent tasks (METs = time spent at each activity in hours/week multiplied by its typical energy
expenditure) [20].
2.5. Outcome Assessment
Incidence of cardiovascular events, defined as non-fatal myocardial infarction, non-fatal stroke
reported by participants on a follow-up questionnaire or deaths due to cardiovascular disease, was
the primary endpoint. An expert panel of physicians, blinded to information on diet, anthropometric
indexes and risk factors, reviewed medical records of participants and adjudicated events applying
universal criteria for myocardial infarction and clinical criteria for the other outcomes. A non-fatal
stroke was defined as a focal neurological deficit of sudden onset and vascular mechanism lasting
>24 h. Cases of fatal stroke were documented if there was evidence of a cerebrovascular mechanism.
Deaths were reported to our research team by the participants’ next of kin, work associates and postal
authorities. For participants lost to follow-up, we consulted the National Death Index every 6 months
to identify deceased cohort members and to obtain their cause of death. Cases of fatal CHD or
stroke reported by families or postal authorities were confirmed by a review of medical records with
permission of the next of kin.
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2.6. Statistical Analyses
Analyses were performed with STATA version 12.0 (StataCorp, College Station, TX 77840, USA).
For descriptive purposes, we calculated means, standard deviations, proportions, medians, and
percentiles of baseline characteristics across levels of adherence to the Mediterranean diet. We used
Cox regression models to assess hazard ratios (HRs) and their 95% confidence intervals (CIs) for total
CVD events across categories of BMI (cut off points: 25 and 30 kg/m2). We used age as the underlying
time variable and stratified all analyses for age groups. To assess attenuation by the MedDiet of the
harmful effect of obesity, we stratified results for baseline adherence to the MedDiet (categorized
into two groups: low adherence (<6 points) and high adherence (ě6 points)). We included as
covariates potential confounders such as age (underlying time variable, plus stratification), sex,
smoking status (3 categories), physical activity during leisure time, baseline hypertension status,
baseline hypercholesterolemia status, diabetes, years of university education, and previous history
of CVD (present in only 173 participants) in multivariable analyses.
We also assessed incidence of cardiovascular events according to four categories of adherence
to MedDiet: low (2 points), low-moderate (3–4 points), moderate-high (5–6 points) and high
(7–9 points). In addition, linear trend test were also conducted using Trichopoulou’s score of
adherence to MedDiet as a continuous variable.
3. Results
Table 1 shows the baseline characteristics of participants according to their baseline adherence
to MedDiet and stratified by their baseline BMI. In addition to having a high level of education, SUN
cohort participants were relatively young at baseline (mean age 38.4 years), more likely to be women
(60.5%) and non-obese (average BMI = 23.5 kg/m2; 95.3% of participants had a BMI < 30 kg/m2).
However, participants with better adherence to MedDiet were older, more physically active, more
likely to be men and married and to follow special diets, and less likely to snacks between meals.
They were also less likely to be current smokers but more prone to being former smokers. In addition,
those participants with initial good adherence to the MedDiet were more likely to have a previous
diagnosis of hypercholesterolemia, hypertriglyceridemia, diabetes or hypertension.
Table 1. Baseline characteristics of participants according to Mediterranean diet adherence and BMI.
Low Adherence to MedDiet (<6/9) High Adherence to MedDiet (ě6/9)
BMI <25 BMI 25–30 BMI >30 BMI <25 BMI 25–30 BMI >30
N 10,169 3396 663 3208 1396 233
Age (years) 35 (10) 43 (13) 45 (12) 39 (12) 48 (12) 48 (13)
Women (%) 74.3 30.4 32.0 71.7 28.2 23.6
BMI (kg/m2) 21.6 (1.9) 26.9 (1.3) 32.5 (2.4) 21.9 (1.9) 26.9 (1.3) 32.7 (3.0)
Previous history of CVD (%) 0.4 1.3 1.5 0.8 3.0 4.3
Energy intake (kcal/day) 2479 (766) 2353 (756) 2386 (812) 2698 (786) 2633 (766) 2715 (800)
Leisure-time physical activity 20.6 (22.1) 20.4 (21.7) 15.2 (17.7) 26.8 (26.0) 24.6 (23.3) 19.7 (18.0)
Marital status
Single 53.5 30.9 27.8 43.6 19.9 5.7
Married 42.4 63.9 65.6 50.7 74.4 70.4
Others 4.0 5.2 6.6 5.7 5.8 7.7
Smoking current smokers (%) 22.9 20.4 19.6 20.8 17.9 18.0
Former smokers (%) 22.6 34.9 39.5 30.5 44.4 48.1
Baseline hypercholesterolemia (%) 11.3 22.5 32.3 17.8 33.0 38.2
Baseline triglycerides (%) 2.9 12.1 23.5 4.4 16.3 30.9
Diabetes at baseline (%) 0.9 2.8 5.7 1.6 3.5 7.3
Hypertension at baseline (%) 3.0 12.5 25.9 5.2 19.3 32.6
Years of university education 5.0 (1.47) 5.2 (1.60) 5.0 (1.51) 5.0 (1.50) 5.3 (1.72) 5.1 (1.50)
Leisure-time spent sitting
down, h/week. 3.8 (1.72) 3.8 (1.91) 3.8 (2.06) 3.9 (1.86) 4.0 (1.83) 4.1 (2.01)
TV watching, h/week. 1.6 (1.23) 1.7 (1.14) 1.8 (1.18) 1.6 (1.16) 1.7 (1.09) 1.8 (1.17)
Between-meal snacking (%) 35.2 34.7 51.3 27.9 29.3 40.8
Following special diets (%) 5.6 9.6 15.1 9.2 12.8 19.3
BMI: body mass index; SD: standard deviation; CVD: cardiovascular disease (acute coronary syndromes
or stroke).
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We observed 152 incident cases of CVD (56 non-fatal myocardial infarctions, 30 non-fatal strokes
and 66 cardiovascular deaths) after a mean of 10.9 years of follow–up. As shown in Table 2,
we assessed the relationship between classical categories of BMI and risk of CVD clinical events
according to categories of baseline adherence to MedDiet (<6 and ě6 points in the Trichopoulou’s
score). An increased risk of CVD events across categories of BMI was apparent in the low adherence
to MedDiet group. Within each group of BMI, the group with lesser conformity to MedDiet had
higher rates of age-adjusted CVD than the group with good adherence to MedDiet.
Table 2. Relative risk (hazard ratios and 95% confidence intervals) of incident cardiovascular disease
(myocardial infarction, stroke or cardiovascular death) according to baseline body mass index and
adherence to MedDiet. The SUN project 1999–2014.
Low Adherence to MedDiet (<6/9) High Adherence to MedDiet (ě6/9)
Body mass index <25 25–30 >30 <25 25–30 >30
n 10,169 3396 663 3208 1396 233
Median body mass index 21.6 26.9 32.5 21.9 26.9 32.7
events 38 59 15 15 19 6
Person-years 95,620 30,961 5814 28,260 11,917 1789
Age-adjusted rate/105 (95% CI) 40 (28–55) 74 (49–113) 97 (53–177) 31 (17–57) 43 (25–76) 86 (36–206)
Sex-, age-adjusted HR 1 (ref.) 1.52 (0.99–2.35) 2.14 (1.14–4.00) 1 (ref.) 0.97 (0.48–1.95) 1.77 (0.61–5.17)
Multivariable-adjusted HR * 1 (ref.) 1.44 (0.93–2.25) 2.00 (1.04–3.83) 1 (ref.) 0.77 (0.35–1.67) 1.15 (0.39–3.43)
* Adjusted for age (underline time variable plus stratification), sex, smoking, baseline hypercholesterolemia,
hypertension, leisure-time physical activity, hypertension, diabetes and previous history of cardiovascular
disease. Robust standard errors were used. p for interaction (BMI ˆMedDiet) = 0.10.
Among participants with low adherence to the MedDiet and compared to participants with
a BMI < 25 kg/m2, multivariable-adjusted hazard ratios (95% confidence intervals) of CVD were
1.44 (0.93–2.25) for participants with a BMI ě25 – <30 kg/m2, and 2.00 (1.04–3.83) for participants
with BMI > 30 kg/m2. On the other hand, in the group with good adherence to the MedDiet,
multivariable-adjusted hazard ratios (HRs) were 0.77 (0.35–1.67) and 1.15 (0.39–3.43), respectively.
Therefore, there was a trend towards an attenuation of the harmful effects of obesity by the MedDiet.
However, the p value for the multiplicative interaction (to test for an effect beyond the multiplication
of both independent effects) was not statistically significant (p = 0.10).
We also confirmed an inverse association between adherence to MedDiet and CVD events
(Table 3), which was previously reported when the accrual in this cohort, measured as person-years,
was smaller [21]. In this updated analysis, participants with the highest adherence (score >7) showed
a 53% lower risk of cardiovascular events as compared to participants in the lowest adherence
category (score <2), after adjustment for potential confounders. The inverse linear trend for the
association between adherence to the MedDiet and CVD was statistically significant (p = 0.029). A
two-point increment in the Mediterranean-diet score was associated with a 7% relative reduction in
CVD risk.
Table 3. Relative risk (Hazard Ratios and 95% confidence intervals) of incident cardiovascular
disease (myocardial infarction, stroke or cardiovascular death) according to baseline adherence to
the MedDiet. The SUN project 1999–2014.
Adherence to the
Mediterranean Diet
Low
0–2
Low-Moderate
3–4
Moderate-High
5–6
High
7–9
p for
Trend
For Each
+2 Points
n 3334 7160 6431 2140
Incident cases of CVD 23 57 51 21
Person-years 32,001 66,900 57,120 18,341
Sex-, age-adjusted HR 1 (ref.) 0.88 (0.53–1.46) 0.68 (0.40–1.15) 0.58 (0.31–1.09) 0.097 0.95 (0.91–0.99)
Multivariable-adjusted HR * 1 (ref.) 0.81 (0.48–1.38) 0.58 (0.34–1.00) 0.47 (0.25–0.89) 0.029 0.93(0.89–0.98)
* Adjusted for age (underline time variable plus stratification), sex, smoking, baseline hypercholesterolemia,
hypertension, leisure-time physical activity, hypertension, diabetes and previous history of cardiovascular
disease. Robust standard errors were used. p for interaction (BMI ˆMedDiet) = 0.10.
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Figure 2 presents multivariable-adjusted hazard ratios for the joint classification according to
both values of BMI (3 groups with the following 2 cut-off points: 25 and 30 kg/m2) and adherence to
MedDiet (two categories: low adherence (<6 points) and high adherence (ě6 points)). The reference
category was the group with low BMI (<25) and high adherence to MedDiet (score ě6). In the group
with better adherence to MedDiet, the risk of CVD was lower than in the poor adherence group across
all BMI categories.
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persons at high cardiovascular risk but also in young, healthier and highly-educated persons. 
Though we did not find a statistically significant interaction and the p value for the product-term 
only approached statistical significance, a biological interaction was suggested by our results. In fact, 
the effect of increased adiposity was mitigated in subjects with high adherence to MedDiet. 
There is evidence that excess body weight is associated with an increased risk of CVD [22,23]. 
Excess weight is associated with both subclinical metabolic and vascular dysfunction that, with the 
passage of time, lead to an increased risk of CV events, due to a state of low-grade inflammation that 
increases cardiovascular risk [24–26]. Therefore, it seems biologically plausible that the MedDiet’s  
anti-inflammatory effects [27] could counter-balance the detrimental effects of obesity-associated 
low-grade inflammation. 
The association between overweight and CVD is not as universally acknowledged as that 
between obesity and CVD. For instance, a recently published meta-analysis suggested that 
overweight subjects (defined as those with a BMI of 25 to 30 kg/m2) have lower all-cause mortality as 
compared to normal weight subjects. In addition, persons with grade I obesity (BMI between 30 and 35 
kg/m2) had a significantly lower risk of mortality [28]. In contrast, in our study an increased risk of CVD 
was observed both in obese and overweight subjects. A possible explanation for this discrepancy lies in 
the presence of potential biases that may have attenuated the association between obesity and CVD risk 
in previous studies conducted with older participants, such as higher rate of tobacco use and presence 
of preclinical diseases. We were able to avoid this problem as our examined sample was composed of 
healthy and young individuals with a low prevalence of pre-existing disease. 
Figure 2. Relative risk of cardiovascular disease (HR and 95% confidence intervals) in the SUN project
according to baseline body mass index and adherence to MedDiet.
4. Discussion
This study contributes to support the evidence that closer adherence to the MedDiet could
counteract some of the adverse cardiovascular effects of overweight/obesity, not only in elderly
persons at high cardiovascular risk but also in young, healthier and highly-educated persons. Though
we did not find a statistically significant interaction and the p value for the product-term only
approached statistical significance, a biological interaction was suggested by our results. In fact, the
effect of increased adiposity was mitigated in subjects with high adherence to MedDiet.
There is evidence that excess body weight is associated with an increased risk of CVD [22,23].
Excess weight is associated with both subclinical metabolic and vascular dysfunction that, with the
passage of time, lead to an increased risk of CV events, due to a state of low-grade inflammation that
increases cardiovascular risk [24–26]. Therefore, it seems biologically plausible that the MedDiet’s
anti-inflammatory effects [27] could counter-balance the detrimental effects of obesity-associated
low-grade inflammation.
The association between overweight and CVD is not as universally acknowledged as that
between obesity and CVD. For instance, a recently published meta-analysis suggested that
overweight subjects (defined as those with a BMI of 25 to 30 kg/m2) have lower all-cause mortality
as compared to normal weight subjects. In addition, persons with grade I obesity (BMI between
30 and 35 kg/m2) had a significantly lower risk of mortality [28]. In contrast, in our study an
increased risk of CVD was observed both in obese and overweight subjects. A possible explanation
for this discrepancy lies in the presence of potential biases that may have attenuated the association
between obesity and CVD risk in previous studies conducted with older participants, such as higher
rate of tobacco use and presence of preclinical diseases. We were able to avoid this problem as
our examined sample was composed of healthy and young individuals with a low prevalence of
pre-existing disease.
We used BMI to measure excess of body weight, as it is the most widely used and accepted index
for assessing obesity. However, anthropometric indexes such as the waist-to-height (WHtR) or waist
circumference (WC) have been shown to have advantages as predictors of CVD [29,30]. Nevertheless,
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weight and height are objective and reproducible measures that have been accurately reported by our
participants in a validation study of self-reported measurements [13].
Previous studies have suggested the beneficial metabolic effects of the MedDiet, regardless of
abdominal adiposity [31–34]. Our results support a previous study that suggested a beneficial effect
from the MedDiet in obese subjects [11]. In addition, we have found evidence that extends this benefit
to overweight subjects.
There are several strengths in our research that deserve to be mentioned. We used a large sample
of participants with a high retention rate. The prospective nature of our study with its long follow-up
period allowed us to detect CVD events and avoid reverse causation bias in the reported associations.
In addition, multiple-adjusted models enabled us to control for a wide array of potential confounders.
We find that our study has a strong internal validity thanks to a high retention rate and
reliable self-reported measures reported by highly educated participants. In addition, internal
validity is reinforced by restriction to subjects with high educational levels so that the risk
for confounding by education or socio-economic levels is minimized. On the other hand, we
acknowledge some limitations of our study. First, the information on several variables was collected
through self-reporting. However, parameters such as self-reported usual diet, weight or BMI have
been previously validated [13], therefore decreasing risk of residual misclassification. In addition,
outcomes were confirmed by a panel of physicians after blindly reviewing participants’ medical
records. Second, the product-term in the fully adjusted model showed a non-significant interaction.
The relatively small number of events observed in our cohort could explain the lack of statistical
significance of this interaction product-term. However, this low number of cardiovascular events
should not be surprising given the young age and healthy characteristics of our participants.
5. Conclusions
Our study suggests benefits from the MedDiet as an effective tool for counteracting the
detrimental effects of obesity on cardiovascular health.
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